ZM223
CAS No. 2031177-48-5
ZM223 ( ZM-223 )
产品货号. M26524 CAS No. 2031177-48-5
ZM223 是 NEDD8 激活酶 (NAE) 的有效非共价抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥2373 | 有现货 |
|
| 5MG | ¥3629 | 有现货 |
|
| 10MG | ¥5330 | 有现货 |
|
| 25MG | ¥7995 | 有现货 |
|
| 50MG | ¥11178 | 有现货 |
|
| 100MG | ¥15309 | 有现货 |
|
| 500MG | ¥30618 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ZM223
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述ZM223 是 NEDD8 激活酶 (NAE) 的有效非共价抑制剂。
-
产品描述ZM223 is a potent non-covalent inhibitor of NEDD8 activating enzyme (NAE).(In Vitro):ZM223 (0.1-1 μM) inhibits cell growth with IC50s of 100 and 122 nM in HCT-116 and U-2OS cancer cells, respectively. ZM223 (0.1-1 μM) dose-dependently reduces the level of NEDD8 and accumulation of the UBC12 protein thereby reducing the subsequent NEDD8-UBC12 complex.
-
体外实验ZM223 (0.1-1 μM; 4 hours) inhibits both HCT-116 and U-2OS cancer cells with IC50s of 100 and 122 nM, respectively.ZM223 (0.1-1 μM; 4 hours) causes a dose-response decrease in the level of NEDD8 and accumulation of the UBC12 protein, indicating the decrease of the subsequent NEDD8-UBC12 complex.Cell Viability Assay Cell Line:HCT116 colon cancer cells and U-2OS osteosarcoma cells Concentration:0.1 μM, 1 μM Incubation Time:4 hours Result:Inhibited both HCT-116 and U-2OS cancer cells.Western Blot Analysis Cell Line:HCT116 colon cancer cells Concentration:0.1 μM, 1 μM Incubation Time:4 hours Result:Caused a decrease in the level of NEDD8 and an increase in the downstream UBC12 protein.
-
体内实验——
-
同义词ZM-223
-
通路Chromatin/Epigenetic
-
靶点Epigenetic Reader Domain
-
受体EGFR
-
研究领域——
-
适应症——
化学信息
-
CAS Number2031177-48-5
-
分子量502.53
-
分子式C23H17F3N4O2S2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 83.33 mg/mL (165.82 mM)
-
SMILESNc1ccc(SCC(=O)Nc2ccc3nc(NC(=O)c4ccc(cc4)C(F)(F)F)sc3c2)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Sargeant P, Farndale RW, Sage SO. ADP- and thapsigargin-evoked Ca2+ entry and protein-tyrosine phosphorylation are inhibited by the tyrosine kinase inhibitors genistein and methyl-2,5-dihydroxycinnamate in fura-2-loaded human platelets. J Biol Chem. 1993 Aug 25;268(24):18151-6.
产品手册
关联产品
-
Molibresib besylate
Molibresib besylate (GSK 525762C; I-BET 762 besylate) 是 BET 溴结构域抑制剂,IC50 为32.5-42.5 nM。
-
BRD4 Inhibitor-20
BRD4 Inhibitor-20 是一种有效的溴结构域蛋白 4 (BRD4) 抑制剂,具有口服活性。 BRD4 Inhibitor-20 对 BRD4 (BD1) 和BRD4 (BD2) 具有抑制活性,IC50 值分别为 19 nM 和 28 nM。 BRD4 Inhibitor-20 在癌细胞系中也具有抗增殖活性。 BRD4 Inhibitor-20 可用于结肠癌等多种癌症的研究。
-
PNZ5
PNZ5 是一种有效的基于异恶唑的泛 BET 抑制剂,具有与成熟的 (+)-JQ1 相似的高选择性和效力。
021-51111890
购物车()
sales@molnova.cn

